Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Aurobindo Pharma

Aurobindo Pharma

Rank: 43

Hyderabad, India
www.aurobindo.com

2020 Revenues ($USD) : $3,115,402,823
2020 Revenues (foreign currencies) : ₹230,985,000,000
2020 R&D spend : $129,209,9445
2020 Number of Employees : 20,000
Fiscal Year End : 3/31/2020
Key People : P.V.Ramprasad Reddy and Mr. K.Nityananda Reddy

Starting in the late 1980s with a single unit manufacturing semi-synthetic penicillin (SSP) in Pondicherry, the Indian company now touts itself as the market leader for SSPs. It has a multi-product portfolio with manufacturing facilities in several countries. On top of antibiotics, it provides therapies in segments including neurosciences, cardiovascular, anti-retroviral, anti-diabetics, and gastroenterology. It boasts one of the largest R&D centers in India and two research centers in the U.S. Aurobindo Pharma is also active in the high-margin specialty generic formulations segment. –CN
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE